{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-011751","form_type":"8-K","ticker":"DSGN","cik":"0001807120","company_name":"Design Therapeutics, Inc.","filed_at":"2022-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.401761+00:00","generated_at":"2026-06-25T01:21:52.805648+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Design Therapeutics stockholders elect three directors, ratify EY as auditor at 2022 annual meeting","bullets":["Shareholders elected Heather Berger, Rodney Lappe, and John Schmid as Class I directors to serve until 2025.","Votes for Berger: 49,858,607; for Lappe: 49,543,074; for Schmid: 49,344,059; with ~1.94M broker non-votes each.","Ratification of Ernst & Young as independent auditor for FY2022 passed with 53,181,814 votes for, 542 against, 36 abstentions.","Meeting held June 15, 2022; 55,781,681 shares outstanding and entitled to vote as of record date April 18, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-011751","json":"https://secwatch.observer/filing/0000950170-22-011751.json","markdown":"https://secwatch.observer/filing/0000950170-22-011751.md","text":"https://secwatch.observer/filing/0000950170-22-011751.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1807120/000095017022011751/0000950170-22-011751-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1807120/000095017022011751/dsgn-20220615.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:21:52.805648+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}